BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ismail R, Phan TNQ, Laffleur F, Csóka I, Bernkop-schnürch A. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery. European Journal of Pharmaceutics and Biopharmaceutics 2020;152:10-7. [DOI: 10.1016/j.ejpb.2020.04.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Nugrahadi PP, Hinrichs WLJ, Frijlink HW, Schöneich C, Avanti C. Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics 2023;15:935. [DOI: 10.3390/pharmaceutics15030935] [Reference Citation Analysis]
2 Jörgensen AM, Wibel R, Bernkop-Schnürch A. Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients. Small 2023;:e2206968. [PMID: 36610004 DOI: 10.1002/smll.202206968] [Reference Citation Analysis]
3 Matteo Jörgensen A, Knoll P, Haddadzadegan S, Fabian H, Hupfauf A, Gust R, Georg Jörgensen R, Bernkop-Schnürch A. Biodegradable arginine based steroid-surfactants: Cationic green agents for hydrophobic ion-pairing. Int J Pharm 2022;630:122438. [PMID: 36464112 DOI: 10.1016/j.ijpharm.2022.122438] [Reference Citation Analysis]
4 Wibel R, Knoll P, Le-Vinh B, Kali G, Bernkop-Schnürch A. Synthesis and evaluation of sulfosuccinate-based surfactants as counterions for hydrophobic ion pairing. Acta Biomater 2022;144:54-66. [PMID: 35292415 DOI: 10.1016/j.actbio.2022.03.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Poudwal S, Shende P. Multi-strategic approaches for enhancing active transportation using self-emulsifying drug delivery system. J Drug Target 2022;:1-24. [PMID: 35451898 DOI: 10.1080/1061186X.2022.2069783] [Reference Citation Analysis]
6 Zuglianello C, Lemos-Senna E. The nanotechnological approach for nasal delivery of peptide drugs: a comprehensive review. J Microencapsul 2022;:1-29. [PMID: 35262455 DOI: 10.1080/02652048.2022.2051626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Haddadzadegan S, Dorkoosh F, Bernkop-Schnürch A. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 2022;182:114097. [PMID: 34999121 DOI: 10.1016/j.addr.2021.114097] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 25.0] [Reference Citation Analysis]
8 Ebada HMK, Nasra MMA, Nassra RA, Abdallah OY. Chondroitin sulfate-functionalized lipid nanoreservoirs: a novel cartilage-targeting approach for intra-articular delivery of cassic acid for osteoarthritis treatment. Drug Deliv 2022;29:652-63. [PMID: 35188017 DOI: 10.1080/10717544.2022.2041130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Saha M, Sikder P, Saha A, Shah S, Sultana S, Emran T, Banik A, Islam Z, Islam MS, Sharker SM, Reza HM. QbD Approach towards Robust Design Space for Flutamide/PiperineSelf-Emulsifying Drug Delivery System with Reduced Liver Injury. AAPS PharmSciTech 2022;23:62. [PMID: 35080685 DOI: 10.1208/s12249-022-02213-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ebada HM, Nasra MM, Nassra RA, Solaiman AA, Abdallah OY. Cationic nanocarrier of rhein based on hydrophobic ion pairing approach as intra-articular targeted regenerative therapy for osteoarthritis. Colloids Surf B Biointerfaces 2021;211:112285. [PMID: 34942464 DOI: 10.1016/j.colsurfb.2021.112285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 González LF, Bevilacqua LE, Naves R. Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases. Pharmaceutics 2021;13:2055. [PMID: 34959337 DOI: 10.3390/pharmaceutics13122055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Noh G, Keum T, Bashyal S, Seo J, Shrawani L, Kim JH, Lee S. Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals. J Pharm Investig 2022;52:75-93. [DOI: 10.1007/s40005-021-00549-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
13 Ren T, Zheng X, Bai R, Yang Y, Jian L. Utilization of PLGA nanoparticles in yeast cell wall particle system for oral targeted delivery of exenatide to improve its hypoglycemic efficacy. Int J Pharm 2021;601:120583. [PMID: 33839225 DOI: 10.1016/j.ijpharm.2021.120583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Ismail R, Baaity Z, Csóka I. Regulatory status quo and prospects for biosurfactants in pharmaceutical applications. Drug Discov Today 2021;26:1929-35. [PMID: 33831583 DOI: 10.1016/j.drudis.2021.03.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
15 Vinarov Z, Abrahamsson B, Artursson P, Batchelor H, Berben P, Bernkop-Schnürch A, Butler J, Ceulemans J, Davies N, Dupont D, Flaten GE, Fotaki N, Griffin BT, Jannin V, Keemink J, Kesisoglou F, Koziolek M, Kuentz M, Mackie A, Meléndez-Martínez AJ, McAllister M, Müllertz A, O'Driscoll CM, Parrott N, Paszkowska J, Pavek P, Porter CJH, Reppas C, Stillhart C, Sugano K, Toader E, Valentová K, Vertzoni M, De Wildt SN, Wilson CG, Augustijns P. Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network. Adv Drug Deliv Rev 2021;171:289-331. [PMID: 33610694 DOI: 10.1016/j.addr.2021.02.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 19.0] [Reference Citation Analysis]
16 Eissa NG, Elsabahy M, Allam A. Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs. Int J Pharm 2021;597:120317. [PMID: 33540005 DOI: 10.1016/j.ijpharm.2021.120317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Friedl JD, Jörgensen AM, Le‐vinh B, Braun DE, Tribus M, Bernkop-schnürch A. Solidification of self-emulsifying drug delivery systems (SEDDS): Impact on storage stability of a therapeutic protein. Journal of Colloid and Interface Science 2021;584:684-97. [DOI: 10.1016/j.jcis.2020.11.051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]